Thomas L.
- Country
- Germany
- Department
- N/A
Research Overview
- Evaluation of Long-Term Safety and Tolerability of Lasmiditan for Acute Migraine Treatment in Pediatric Patients: A 12-Month Open-Label Study
- Non-Inferiority Study of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Multiple Sclerosis Patients Over Two Years
- Evaluation of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis: A Two-Year, Double-Blind, Randomized, Multicenter Study
Data & Insights
Has run more than one trial at 33 of 61 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the treatment and research of multiple sclerosis, with particular emphasis on pediatric populations. Their work encompasses comprehensive evaluation of therapeutic interventions for young patients with MS.
- Pediatric Multiple Sclerosis
- Long-term Disease Management
- Neurological Treatment Efficacy
The investigator focuses on assessing innovative therapeutic approaches in pediatric MS care.
Developmental Medicine
The investigator's research interests extend to studying the impact of treatments on cognitive function and developmental aspects in young patients. Their work examines the intersection of neurological treatment and physical development.
- Cognitive Development Assessment
- Physical Development Monitoring
- Sexual Development Evaluation
Their research considers the comprehensive developmental impacts of neurological treatments in pediatric populations.
Clinical Safety Assessment
The investigator specializes in evaluating long-term safety profiles and treatment tolerability in neurological interventions. Their expertise includes comparative assessment of different therapeutic approaches.
- Treatment Safety Monitoring
- Long-term Efficacy Assessment
- Therapeutic Tolerability Studies
Their work encompasses thorough evaluation of treatment safety parameters in pediatric neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
